Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

Advances in adjuvant and neoadjuvant systemic therapies are continuing to improve recurrence-free and distant metastasis-free survival rates in patients with advanced melanoma. With treatment ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

The charter captain and Below Deck Down Under star recently spoke to PEOPLE about being diagnosed with melanoma in December after noticing changes in a sunspot on his left side. “I had a little ...

Exploring innovative solutions to improve the healthcare of the aging and diseased population continues to be a global challenge. Among a number of strategies toward this goal, tissue engineering and ...